The largest database of trusted experimental protocols

5 protocols using ab 406 na

1

Proliferation Effects of IL6 Neutralization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Il6 neutralizing experiments Il6 neutralizing antibody (R&D, AB-406-NA) and control IgG antibody (R&D, AB-108) were used to assess effects of secreted Il6 on the proliferation of MEFs. The Stat3 inhibitor WP1066 (Selleckchem, S2796), PI3K inhibitor LY294002 (Cell Signaling, #9901), Rapamycin (Cell Signaling, #9904) and JAK inhibitor I (Calbiochem, 420099) were resuspended in DMSO. JQ1 was a kind gift from Dr. J. Bradner (Harvard Medical School) and was used as described previously (31 (link)). Note that the IC50 value for inhibition of proliferation was 1.4 μM for Pten/Trp53-deleted cells, and 3.3 μM for wt cells. These results are in similar range to earlier reported, WP1066 effects on cell survival, proliferation and Stat3 phosphorylation (54 (link)–56 (link)).
+ Open protocol
+ Expand
2

Neutralizing TGF-β and IL-6 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To neutralize TGF-β, mice were treated with a single dose of a polyclonal TGF-β-neutralizing antibody (AB-100-NA; 100 μg/mouse in 100 μl saline; R & D Systems) at 2 d.p.i. by intraperitoneal (i.p.) injection (7 (link)). To neutralize IL-6, mice were treated i.p. with a single dose of a polyclonal antibody to IL-6 (AB-406-NA; 0.5 μg/mouse in 100 μl saline; R & D Systems) at 4 d.p.i. (56 (link)). Controls were treated i.p. with rabbit IgG at both time points (100 μg/mouse in 100 μl saline; Southern Biotech, Birmingham, AL).
+ Open protocol
+ Expand
3

Antibody-Mediated Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary Abs against MyoD (18943-1-AP) and MyoG (67082-1-Ig) were purchased from Proteintech (Wuhan, Hubei, China). The monoclonal neutralization Abs against IL-6 (AB-406-NA) and TNFα (AB-410-NA), and recombinant mouse proteins IL-6 and TNFα, were purchased from R&D Systems (Minneapolis, MN, USA). Fluorescein (FITC)-conjugated AffiniPure goat anti-mouse IgG (H+L) was obtained from KeyGEN Biotechnology (Nanjing, Jiangsu, China). DCFH-DA, NAC, tBHP, DPI and ROT were purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
4

Immunohistochemical Detection of IL-6 in Lung Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thin sections (3 μm) were prepared from formalin-fixed, paraffin-embedded lung tissue (31 (link)). IL-6 was detected using a goat polyclonal antibody (AB-406-NA; R & D Systems, Minneapolis, MN). Bound antibody was detected using biotinylated anti-goat immunoglobulin (Vector Laboratories, Burlingame, CA), the Vectastain ABC peroxidase system, and 3,3′-diaminobenzidine substrate (Vector Laboratories). Sections were counterstained with Harris hematoxylin, scanned with a Scanscope CS slide scanner (Aperio Technologies, Vista, CA), and visualized with ImageScope software (Aperio Technologies).
+ Open protocol
+ Expand
5

Modulating Immune Responses in Melanoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
To deplete NK cells, mice received anti-Asialo GM 1 antibodies (1 mg/ml, EBio-Science) or isotype antibodies as control (Rabbit IgG, 0.5 mg/ml, Southern Biotech) every second day from 1 week before B16 inoculation. Five days after tumor cell inoculation, NK cells content was evaluated. Propranolol/Epinephrine Study Eight-week-old C57BL/6 mice were randomized to drinking water containing 0.5 g/l propranolol or nothing. Propranolol administration started 1 week before B16 inoculation. An additional group received daily (Monday to Friday) injections of epinephrine (0.5 mg/kg, 200 ml i.p.) from 1 week before B16 inoculation. For the acute effect of epinephrine, mice were injected with 0.5 mg/kg or 2 mg/kg epinephrine, and sacrified after 30 min, where blood, spleen, and muscle tissue were collected. Anti-IL-6/IL-6 Study Eight-week-old C57BL/6 mice were randomized to groups, receiving i.p. injections of anti-IL-6 antibodies (100 mg/mouse, R&D systems, #AB-406-NA) or vehicle injections twice a week from 1 week before B16 inoculation. An additional group received daily (Monday to Friday) injections of IL-6 (100 ng/mouse, R&D systems, #406-ML-025/CF) from 1 week before B16 inoculation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!